What Is HPLC Purity Testing for Research Peptides?

When a research peptide is described as "99% pure", that figure almost always comes from HPLC analysis. Understanding what the test measures — and what it does not — is essential for any researcher evaluating material. This is a technical explainer for Australian researchers; it does not discuss human use.

What HPLC measures

High-Performance Liquid Chromatography (HPLC) is an analytical technique that separates the components of a sample. The sample is pushed through a column under high pressure, and its components emerge at different times based on their chemical properties. A detector records each as a peak on a chromatogram. The area of the target peak relative to all peaks is reported as the purity percentage — so a high figure means the target compound dominates and impurities are minimal.

How the separation works

The column is packed with a stationary phase, and a liquid mobile phase carries the sample through it. Components that interact strongly with the stationary phase move slowly and emerge late; those that interact weakly move quickly and emerge early. For peptide analysis the usual configuration is reversed-phase HPLC, where the stationary phase is non-polar and separation is driven largely by hydrophobicity. Because closely related peptide sequences differ only slightly in hydrophobicity, the resolving power of the method — its ability to pull two similar species apart into distinct peaks — is what determines how informative the resulting purity figure is.

Reading the chromatogram

The chromatogram is a plot of detector response against retention time. A well-resolved analysis shows a dominant peak that is sharp and symmetrical, returning cleanly to the baseline on either side, with any minor peaks clearly separated from it. Warning signs include a broad or asymmetric main peak, shoulders that suggest a co-eluting species hidden under the main signal, a baseline that does not settle, or a run truncated so early that late-eluting components would never have appeared. A purity figure calculated from a poor separation can be numerically high and still meaningless.

What HPLC does not measure

The percentage reports relative peak area among what the detector saw. It does not report anything the method could not detect or did not have time to elute, and it says nothing about residual solvents, water content, counterions, or endotoxin. It also says nothing about identity. These are separate questions requiring separate methods, which is why a certificate reporting only a purity percentage is a partial characterisation rather than a complete one.

What LC-MS adds: identity

HPLC tells you how pure a sample is, but not definitively what it is. That is the role of mass spectrometry, often coupled with chromatography as LC-MS (Liquid Chromatography–Mass Spectrometry). It measures the molecular mass of the compound and confirms it matches the expected value for the target peptide. Purity and identity are two different questions, and a complete analysis answers both.

Why a pure sample can still be the wrong compound

Consider a synthesis in which a single residue was substituted, or a batch that was mislabelled upstream. The material may be a highly pure single species and produce an excellent chromatogram, because purity measures homogeneity rather than correctness. Only a measurement of molecular mass reveals that the homogeneous species present is not the sequence the label names. This is the specific failure mode that identity confirmation exists to catch, and it is the reason mass spectrometry is not an optional extra on a certificate.

• HPLC: separates components and reports purity as a percentage
• The chromatogram: shows whether the main peak is clean and sharp
• LC-MS: confirms molecular identity by measuring mass
• Together: they establish both how pure and what the material is

Where peptide impurities come from

Understanding what the impurity fraction consists of makes it easier to judge what a purity figure is worth. Synthetic peptides are typically assembled by solid-phase synthesis, one residue at a time, on a resin support. Each coupling step proceeds at slightly less than complete efficiency, and the small fraction that fails at each step accumulates across the sequence.

• Deletion sequences: chains missing one or more residues from a failed coupling
• Truncated sequences: chains where synthesis terminated before completion
• Incompletely deprotected species: side-chain protecting groups not fully removed at cleavage
• Oxidation or modification products formed during synthesis, cleavage, or storage
• Residual solvents, scavengers, and counterions carried through from processing

Why the hardest impurities to remove are the ones closest to the target

A deletion sequence missing one residue out of fifteen is chemically almost identical to the intended product. It has nearly the same hydrophobicity, which means it elutes at nearly the same retention time and is the most difficult species to resolve from the main peak. Longer and more heavily modified sequences accumulate more of these near-neighbours, which is why the same nominal purity figure represents a different degree of achievement for a short unmodified peptide than for a long lipidated one. It is also why the shape of the main peak, not just the number attached to it, carries real information.

What a purity figure actually means

A purity figure is only as meaningful as the method and the documentation behind it. A number on a label, with no chromatogram and no testing laboratory named, tells you very little. A purity figure backed by a viewable chromatogram, the method used, and mass-spec identity confirmation is far more informative — it lets you assess the result rather than simply trust it.

Questions worth asking about any purity claim

• Which laboratory performed the analysis, and is it independent of the supplier?
• Is the chromatogram reproduced, or only a summary figure?
• Is the main peak sharp, symmetrical, and well resolved from its neighbours?
• Was identity confirmed by mass spectrometry against the expected mass?
• Does the batch or lot identifier match the vial you were sent?
• Was the certificate available before purchase or only afterwards?

Why independent testing matters for reproducibility

Research reproducibility depends on knowing exactly what is in the vial. An in-house purity claim is a claim; an independent, third-party Certificate of Analysis is verification. When the testing is performed by an external laboratory and the COA is published before purchase, a researcher can characterise their starting material accurately — and that is the foundation of reproducible experiments. For more on reading these documents, see our COA guide, and for evaluating suppliers, see our supplier checklist.

The cost of an uncharacterised starting material

If the identity or purity of a starting material is uncertain, every result generated from it inherits that uncertainty. An unexpected outcome cannot be attributed with confidence to the biology under study, because the alternative explanation — that the material was not what it was assumed to be — cannot be excluded. That is not a small inconvenience: it means the work cannot be interpreted and generally cannot be published. Characterisation up front is considerably cheaper than discovering the problem after an experiment is complete.

Batch-to-batch consistency

For work that runs over months, the relevant question extends beyond a single certificate to whether successive batches are comparable. A supplier that publishes certificates across a series of production runs is showing something a single document cannot: that its manufacturing and testing arrangements produce consistent material over time. Where an experiment spans more than one batch, recording which batch was used at which point is what allows a shift in results to be traced to its source rather than left unexplained.